企業プロフィール
Kazia Therapeutics Limited 株価・ニュース・カタリスト
- ティッカー:
- KZIA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Australia and listed in the U
株価パフォーマンス
13.56 USD (+0.30%)
終値
最終更新: 2026年8月17日
135M USD
時価総額
株価変動の要因
As of Aug 17, 2026, KZIA closed up 0.30% at $13.56. No new same-company headline was identified in the current news window.
企業概要
事業概要
Kazia Therapeutics is an oncology biotechnology company focused on targeted cancer therapies, including programs aimed at difficult solid tumors and brain tumors. Its story is built around trying to create meaningful value from a specialized oncology pipeline.
所在地とセクター分類
Kazia is headquartered in Australia and listed in the U.S. market. It sits in small-cap oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical data, translational confidence, and the ability to fund a narrow cancer pipeline. Investors usually watch proof-of-concept work and strategic changes.
バイオ業界での位置付け
Kazia occupies a specialized oncology niche within biotech. It is highly catalyst-sensitive because the company is still proving whether the platform can matter clinically.
今後のカタリスト
- Kazia’s catalysts are paxalisib and the oncology / brain-cancer program, where the next update can materially change the market’s view. The stock remains very much a data story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。